Yang, H., Chen, C., Chen, H., Duan, X., Li, J., Zhou, Y., . . . Yang, L. (2020). Navitoclax (ABT263) reduces inflammation and promotes chondrogenic phenotype by clearing senescent osteoarthritic chondrocytes in osteoarthritis. Aging (Albany NY).
Citación estilo ChicagoYang, Hao, Cheng Chen, Hao Chen, Xiaojun Duan, Juan Li, Yi Zhou, Weinan Zeng, y Liu Yang. "Navitoclax (ABT263) Reduces Inflammation and Promotes Chondrogenic Phenotype By Clearing Senescent Osteoarthritic Chondrocytes in Osteoarthritis." Aging (Albany NY) 2020.
Cita MLAYang, Hao, et al. "Navitoclax (ABT263) Reduces Inflammation and Promotes Chondrogenic Phenotype By Clearing Senescent Osteoarthritic Chondrocytes in Osteoarthritis." Aging (Albany NY) 2020.
Precaución: Estas citas no son 100% exactas.